In summary, RBM15 is markedly overexpressed in NSCLC and LUAD, where it regulates diverse biological processes—including ferroptosis, cuproptosis, metabolic reprogramming, EMT, and immune modulation—through distinct m6A-dependent signaling pathways. The gene discussed is RBM15; the disease is non-small cell lung carcinoma.